US4287341A
(en)
*
|
1979-11-01 |
1981-09-01 |
Pfizer Inc. |
Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
|
US6723727B1
(en)
*
|
1996-12-20 |
2004-04-20 |
Hoechst Aktiengesellschaft |
Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
|
EP0903344B1
(fr)
*
|
1997-08-21 |
2011-01-26 |
Shiseido Co., Ltd. |
Dérivés de quinazolin-4-one, leur préparation et leur utilisation comme agents favorisant la croissance des cheveux ou dans une composition pour la peau à usage externe
|
EP1216242A1
(fr)
|
1999-10-01 |
2002-06-26 |
Advanced Medicine, Inc. |
Quinazolinones macrocycliques et leur utilisation en tant qu'anesthesiques locaux
|
US6667300B2
(en)
*
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
EP1278748B1
(fr)
*
|
2000-04-25 |
2011-03-23 |
ICOS Corporation |
Inhibiteurs de la phosphatidyl-inositol 3-kinase delta humaine
|
AUPR201600A0
(en)
*
|
2000-12-11 |
2001-01-11 |
Fujisawa Pharmaceutical Co., Ltd. |
Quinazolinone derivative
|
WO2003020280A2
(fr)
*
|
2001-09-05 |
2003-03-13 |
Minerva Biotechnologies Corporation |
Compositions et methodes de traitement du cancer
|
EP2329822A1
(fr)
|
2001-09-05 |
2011-06-08 |
Minerva Biotechnologies Corporation |
Compositions et procédés pour le traitement du cancer
|
EP1444209A4
(fr)
|
2001-11-07 |
2005-02-16 |
Merck & Co Inc |
Inhibiteurs de la kinesine mitotique
|
AUPS019702A0
(en)
*
|
2002-01-29 |
2002-02-21 |
Fujisawa Pharmaceutical Co., Ltd. |
Condensed heterocyclic compounds
|
JP2005536553A
(ja)
*
|
2002-08-21 |
2005-12-02 |
サイトキネティクス・インコーポレーテッド |
化合物、組成物および方法
|
JP2006512315A
(ja)
*
|
2002-11-04 |
2006-04-13 |
エヌピーエス ファーマスーティカルズ インコーポレイテッド |
カルシリティックとしてのキナゾリノン化合物
|
EP1646615B1
(fr)
*
|
2003-06-06 |
2009-08-26 |
Vertex Pharmaceuticals Incorporated |
Derives de pyrimidne utilises en tant que modulateurs de transporteurs de cassette de liaison a l'atp
|
US20050054614A1
(en)
*
|
2003-08-14 |
2005-03-10 |
Diacovo Thomas G. |
Methods of inhibiting leukocyte accumulation
|
US20050043239A1
(en)
*
|
2003-08-14 |
2005-02-24 |
Jason Douangpanya |
Methods of inhibiting immune responses stimulated by an endogenous factor
|
EP1761540B1
(fr)
*
|
2004-05-13 |
2016-09-28 |
Icos Corporation |
Quinazolinones utilisees en tant qu'inhibiteurs de la phosphatidylinositol 3-kinase delta humaine
|
EP1755609A1
(fr)
*
|
2004-05-25 |
2007-02-28 |
Icos Corporation |
Methodes de traitement et/ou de prevention de la proliferation aberrante des cellules hematopoietiques
|
AU2006214190A1
(en)
*
|
2005-02-17 |
2006-08-24 |
Icos Corporation |
Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
|
EP2233472B1
(fr)
*
|
2006-03-28 |
2014-01-15 |
Atir Holding S.A. |
Composés hétérocycliques et leurs utilisations dans le traitement de troubles sexuels
|
US9492449B2
(en)
|
2008-11-13 |
2016-11-15 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
CA3092449A1
(fr)
|
2008-11-13 |
2010-05-20 |
Gilead Calistoga Llc |
Therapies pour tumeurs malignes hematologiques
|
MX2011009955A
(es)
|
2009-03-24 |
2011-11-18 |
Gilead Calistoga Llc |
Atropisomeros de derivados de 2-purinil-3-tolil-quinazolinona y metodos de uso.
|
CN102458410A
(zh)
*
|
2009-04-20 |
2012-05-16 |
吉联亚·卡利斯托加有限责任公司 |
治疗实体瘤的方法
|
MX2012000817A
(es)
|
2009-07-21 |
2012-05-08 |
Gilead Calistoga Llc |
Tratamiento para desordenes del higado con inhibidores pi3k.
|
BRPI1003506B1
(pt)
|
2010-09-24 |
2019-12-03 |
Ache Int Bvi Ltd |
composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a
|
US9353067B2
(en)
|
2011-04-10 |
2016-05-31 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
AU2013203620B2
(en)
|
2012-03-05 |
2015-11-19 |
Gilead Calistoga Llc |
Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
|
ES2595240T3
(es)
|
2012-07-09 |
2016-12-28 |
Lupin Limited |
Derivados de tetrahidroquinazolinona como inhibidores de PARP
|
PL3083630T3
(pl)
|
2013-12-20 |
2020-02-28 |
Gilead Calistoga Llc |
Sposoby otrzymywania inhibitorów 3-kinazy fosfatydyloinozytolu
|
JP2017500319A
(ja)
|
2013-12-20 |
2017-01-05 |
ギリアード カリストガ エルエルシー |
(s)−2−(1−(9h−プリン−6−イルアミノ)プロピル)−5−フルオロ−3−フェニルキナゾリン−4(3h)−オンの塩酸塩の多形形態
|
NZ726360A
(en)
|
2014-06-13 |
2018-04-27 |
Gilead Sciences Inc |
Phosphatidylinositol 3-kinase inhibitors
|